ISSN: 1945-7553
CODEN: JTEVAB
Page Count: 4

Risk Assessment for Halogenated Solvents

Travis, CC
Office of Risk Analysis, Oak Ridge National Laboratory, Oak Ridge, TN

Abstract

A recent development in the cancer risk area is the advent of biologically based pharmacokinetic and pharmacodynamic models. These models allow for the incorporation of biological and mechanistic data into the risk assessment process. These advances will not only improve the risk assessment process for halogenated solvents but will stimulate and guide basic research in the biological area.

Keywords:
pharmacokinetics, pharmacodynamics, risk assessment

Paper ID: JTE11099J
DOI: 10.1520/JTE11099J
ASTM International is a member of CrossRef.